Inclusion Criteria~* Diagnostic evidence of probable Alzheimer's disease (AD) consistent with the Diagnostic
and Statistical Manual for Mental Disorders-version IV (DSM-IV)~* Hachinski Ischemic Score~* Functional
Assessment Staging (FAST) scale greater than or equal to 6 at Screening.~* Mini-Mental State Examination (MMSE)
score of 1 to 12 at Screening~* Subjects who are on a stable Aricept- dose of 10 mg immediate release (IR),
taken as a single, daily dose for 3 months prior to the Screening Visit~* Evidence consistent with Alzheimer's
disease (AD) on any cranial image on magnetic resonance imaging (MRI) or computed tomography (CT) scan or etc.
obtained within 24 months prior to the Screening Visit. Subjects who have any observations of dementia other
than Alzheimer's type after the last image diagnosis should be reconfirmed.~* Age 50 years~* Written informed
consent is to have been obtained from the subject (if possible) or from the subject's legal guardian or other
representative~
